Forced homo- and heterodimerization of all gp130-type receptor complexes leads to constitutive ligand-independent signaling and cytokine-independent growth

Molecular Biology of the Cell

Volumn 21, Issue 15, 2010, Pages 2797-2807

  Suthaus, Jan ^a   Tillmann, Anna ^a   Lorenzen, Inken ^a   Bulanova, Elena ^b   Rose John, Stefan ^a   Scheller, Jürgen ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOSTATIN M RECEPTOR; PROTEIN WSX 1; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; GENETIC TRANSCRIPTION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

ANIMALS; CATTLE; CELL LINE; CELL PROLIFERATION; CYTOKINE RECEPTOR GP130; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; LIGANDS; MICE; MULTIPROTEIN COMPLEXES; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 77955106518     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-03-0240     Document Type: Article

References (50)

1. Bernard, J., et al. (2004). Identification of an interleukin-15alpha receptor-binding site on human interleukin-15. J. Biol. Chem. 279, 24313-24322.
2. Boulanger, M. J., Chow, D.-C., .revnova, E. E., and Garcia, K. C. (2003). Hexameric structure and assembly of the interleukin-6/IL-6 α receptor/gp130 complex. Science 300, 2101-2104.
3. Brandt, K., Bulfone-Paus, S., Foster, D. C., and Rückert, R. (2003). Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102, 4090-4098.
4. Bromberg, J. (2002). Stat proteins and oncogenesis. J. Clin. Invest. 109, 1139-1142.
5. Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., and Darnell, J. E. (1999). Stat3 as an oncogene. Cell 98, 295-303.
6. Bulfone-Paus, S., Bulanova, E., Budagian, V., and Paus, R. (2006). The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. BioEssays 28, 362-377.
7. Carr, P. D., Gustin, S. E., Church, A. P., Murphy, J. M., Ford, S. C., Mann, D. A., Woltring, D. M., Walker, I., Ollis, D. L., and Young, I. G. (2001). Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration. Cell 104, 291-300.
8. Catlett-Falcone, R., et al. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115.
9. Chattopadhyay, S., Tracy, E., Liang, P., Robledo, O., Rose-John, S., and Baumann, H. (2007). Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J. Biol. Chem. 282, 3014-3026.
10. Cichy, J., Rose-John, S., and Pure, E. (1998). Regulation of the Type II OSM receptor expression in human lung-derived epithelial cells. FEBS Lett. 429, 412-416. (Pubitemid 28300403)
11. Constantinescu, S. N., Keren, T., Socolovsky, M., Nam, H., Henis, Y. I., and Lodish, H. F. (2001). Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc. Natl. Acad. Sci. USA 98, 4379-4384.
12. Demirci, G., and Li, X. C. (2004). IL-2 and IL-15 exhibit opposing effects on Fas mediated apoptosis. Cell. Mol. Immunol. 1, 123-128.
13. Dillon, S. R., et al. (2004). Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5, 752-760.
14. Duitman, E. H., Orinska, Z., Bulanova, E., Paus, R., and Bulfone-Paus, S. (2008). How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Mol. Cell. Biol. 28, 4851-4861.
15. Fang, J., Qian, J. J., Yi, S., Harding, T. C., Tu, G. H., VanRoey, M., and Jooss, K. (2005) Stable antibody expression at therapeutic levels using the 2A peptide. Nat. Biotechnol. 23, 584-590.
16. Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P., Kallen, K. J., Wollmer, A., Grotzinger, J., and Rose-John, S. (1997). A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 15, 145-145.
17. Frank, S. J. (2002). Receptor dimerization in GH and erythropoietin action-it takes two to tango, but how? Endocrinology 143, 2-10.
18. Gearing, D. P., Ziegler, S. F., Comeau, M. R., Friend, D., Thoma, B., Cosman, D., Park, L., and Mosley, B. (1994). Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc. Natl. Acad. Sci. USA 91, 1119-1123.
19. Giese, B., Roderburg, C., Sommerauer, M., Wortmann, S. B., Metz, S., Heinrich, P. C., and Muller-Newen, G. (2005). Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J. Cell Sci. 118, 5129-5140.
20. Greiser, J. S., Stross, C., Heinrich, P. C., Behrmann, I., and Hermanns, H. M. (2002). Orientational constraints of the gp130 intracellular juxtamembrane domain for signaling. J. Biol. Chem. 277, 26959-26965.
21. Hanick, N. A., Rickert, M., Varani, L., Bankovich, A. J., Cochran, J. R., Kim, D. M., Surh, C. D., and Garcia, K. C. (2008). Elucidation of the interleukin-15 binding site on its alpha receptor by NMR. Biochemistry 46, 9453-9461.
22. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Müller-Newen, G., and Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20.
23. Hibi, M., Nakajima, K., and Hirano, T. (1996). IL-6 cytokine family and signal transduction: a model of the cytokine system. J. Mol. Med. 74, 1-12.
24. Jenkins, B. J., et al. (2005). Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat. Med. 11, 845-852.
25. Kallen, K.-J., Grötzinger, J., Lelièvre, E., Vollmer, P., Aasland, D., Renné, C., Müllberg, J., Meyer zum Büschenfelde, K.-H., Gascan, H., and Rose-John, S. (1999). Receptor recognition sites of cytokines are organized as exchangeable modules: transfer of the LIFR binding site from CNTF to IL-6. J. Biol. Chem. 274, 11859-11867.
26. Ketteler, R., Glaser, S., Sandra, O., Martens, U. M., and Klingmuller, U. (2002). Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors. Gene Ther. 9, 477-487.
27. Krause, C. D., Mei, E., Xie, J., Jia, Y., Bopp, M. A., Hochstrasser, R. M., and Pestka, S. (2002). Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells. Mol. Cell. Proteom. 1, 805-815.
28. Kurth, I., Horsten, U., Pflanz, S., Timmermann, A., Kuster, A., Dahmen, H., Tacken, I., Heinrich, P. C., and Muller-Newen, G. (2000). Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J. Immunol. 164, 273-282.
29. Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., and Wilson, I. A. (1999). Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987-990. (Pubitemid 29100256)
30. Lorenzen, I., Dingley, A. J., Jacques, Y., and Grotzinger, J. (2006). The structure of the interleukin-15 alpha receptor and its implications for ligand binding. J. Biol. Chem. 281, 6642-6647.
31. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rössner, S., Koch, F., Romani, N., and Schuler, G. (1999). An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92.
32. Mortier, E., Quemener, A., Vusio, P., Lorenzen, I., Boublik, Y., Grotzinger, J., Plet, A., and Jacques, Y. (2006). Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma hyperagonist IL-15 x IL-15R alpha fusion proteins. J. Biol. Chem. 281, 1612-1619.
33. O'Shea, E. K., Rutkowski, R., Stafford, W. F., and Kim, P. S. (1989). Preferential heterodimer formation by isolated leucine zippers from fos and jun. Science 245, 646-648.
34. Owaki, T., Asakawa, M., Morishima, N., Mizoguchi, I., Fukai, F., Takeda, K., Mizuguchi, J., and Yoshimoto, T. (2008). STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production. J. Immunol. 180, 2903-2911.
35. Patel, N., Herrman, J. M., Timans, J. C., and Katelein, R. A. (1996). Functional replacement of cytokine receptor extracellular domains by leucine zippers. J. Biol. Chem. 271, 30386-30391.
36. Pettit, D. K., Bonnert, T. P., Eisenman, J., Srinivasan, S., Paxton, R., Beers, C., Lynch, D., Miller, B., Yost, J., Grabstein, K. H., and Gombotz, W. R. (1997). Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling. J. Biol. Chem. 272, 2312-2318.
37. Pflanz, S., Hibbert, L., Mattson, J., D., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R., and Kastelein, R. A. (2004). WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231.
38. Rawat, R., Rainey, G. J., Thompson, C. D., Frazier-Jessen, M. R., Brown, R. T., and Nordan, R. P. (2000). Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6 independent phenotype by murine plasmacytomas and hybridomas. Blood 96, 3514-3521.
39. Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., and Zucman-Rossi, J. (2008). Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457, 200-204.
40. Remy, I., Wilson, I. A., and Michnick, S. W. (1999). Erythropoietin receptor activation by a ligand-induced conformation change. Science 283, 990-993.
41. Scheller, J., Grötzinger, J., and Rose-John, S. (2006). Updating IL-6 classic- and trans-signaling. Signal Transduction 6, 240-259.
42. Schuster, B., Meinert, W., Rose-John, S., and Kallen, K.-J. (2003). The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane. FEBS Lett. 538, 113-116.
43. Selander, K. S., Li, L., Watson, L., Merrell, M., Dahmen, H., Heinrich, P. C., Muller-Newen, G., and Harris, K. W. (2004). Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res. 64, 6924-6933.
44. Skiniotis, G., Boulanger, M. J., Garcia, K. C., and Walz, T. (2005). Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat. Struct. Mol. Biol. 12, 545-551.
45. Skiniotis, G., Lupardus, P. J., Martick, M., Walz, T., and Garcia, K. C. (2008). Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol. Cell 31, 737-748.
46. Stuhlmann-Laeisz, C., Lang, S., Chalaris, A., Paliga, K., Sudarman, E., Eichler, J., Klingmüller, U., Samuel, M., Ernst, M., Rose-John, S., and Scheller, J. (2006). Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine independent growth and blockade of differentiation of embryonic stem cells. Mol. Biol. Cell 17, 2986-2995.
47. Taga, T., and Kishimoto, T. (1997). gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15, 797-819.
48. Tenhumberg, S., Schuster, B., Zhu, L., Kovaleva, M., Scheller, J., Kallen, K. J., and Rose-John, S. (2006). gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes. Biochem. Biophys. Res. Commun. 346, 649-657.
49. Vassar, R., Kovacs, D. M., Yan, R., and Wong, P. C. (2009). The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J. Neurosci. 29, 12787-12794.
50. Wang, X., Rickert, M., and Garcia, K. C. (2005). Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 310, 1159-1163.